{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T13:11:38Z","timestamp":1794748298069,"version":"4.9.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["101-CX001038"],"award-info":[{"award-number":["101-CX001038"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["CX001-698-01A2"],"award-info":[{"award-number":["CX001-698-01A2"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["IK2  CX002065"],"award-info":[{"award-number":["IK2  CX002065"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["NIRG-305779"],"award-info":[{"award-number":["NIRG-305779"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["NIRG-362697"],"award-info":[{"award-number":["NIRG-362697"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RF1AG054156"],"award-info":[{"award-number":["RF1AG054156"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R56AG057768"],"award-info":[{"award-number":["R56AG057768"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RFAG057768"],"award-info":[{"award-number":["RFAG057768"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K23AG046377"],"award-info":[{"award-number":["K23AG046377"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["U19AG068753"],"award-info":[{"award-number":["U19AG068753"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG08122"],"award-info":[{"award-number":["AG08122"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["AG054076"],"award-info":[{"award-number":["AG054076"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30AG13846"],"award-info":[{"award-number":["P30AG13846"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["0572063345-5"],"award-info":[{"award-number":["0572063345-5"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["50204517"],"award-info":[{"award-number":["50204517"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U54NS115266"],"award-info":[{"award-number":["U54NS115266"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U01NS086659"],"award-info":[{"award-number":["U01NS086659"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["K23NS102399"],"award-info":[{"award-number":["K23NS102399"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["75N92019D0031"],"award-info":[{"award-number":["75N92019D0031"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"crossref","award":["HHSN2682015000011"],"award-info":[{"award-number":["HHSN2682015000011"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"crossref","award":["PRAP 1367017"],"award-info":[{"award-number":["PRAP 1367017"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Cerebrospinal fluid (CSF) tau and beta-amyloid levels in chronic traumatic encephalopathy (CTE), a disease which can be clinically indistinguishable from Alzheimer\u2019s disease (AD), are largely unknown. We examined postmortem CSF analytes among participants with autopsy confirmed CTE and AD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this cross-sectional study 192 participants from the Boston University AD Research Center, VA-BU-CLF Center, and Framingham Heart Study (FHS) had post-mortem CSF collected at autopsy. Participants were divided into pathological groups based on AD and CTE criteria, with 61 CTE participants (18 low, 43 high stage), 79 AD participants (23 low, 56 intermediate to high), 11 participants with CTE combined with AD, and 41 participants lacking both CTE and AD neuropathology. The Meso Scale Discovery immunoassay system was utilized to measure amyloid-beta (A\u03b2<jats:sub>1-40,<\/jats:sub> A\u03b2<jats:sub>1-42<\/jats:sub>)<jats:sub>,<\/jats:sub> total tau (t-tau), and phosphorylated tau (p-tau<jats:sub>181<\/jats:sub> and p-tau<jats:sub>231<\/jats:sub>). CSF analytes were then compared across the pathological groups: no CTE\/no AD (control), Low CTE, Low AD, High CTE, Intermediate\/High AD, and AD+CTE.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among the Low disease state groups, the Low CTE group had significantly higher levels of p-tau<jats:sub>231<\/jats:sub> versus the control group and compared to the Low AD group. The Low CTE group was also found to have significantly lower levels of A\u03b2<jats:sub>1-42<\/jats:sub> compared to the control group. The high CTE group had higher levels of p-tau<jats:sub>231<\/jats:sub> and lower levels of A\u03b2<jats:sub>1-42<\/jats:sub> compared to Intermediate\/High AD group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Importantly, p-tau<jats:sub>231<\/jats:sub> and A\u03b2<jats:sub>1-42<\/jats:sub> were predictors of diagnosis of CTE vs. control and CTE vs. AD. Increased CSF p-tau<jats:sub>231<\/jats:sub> is a promising potentially sensitive biomarker of CTE, and CSF A\u03b2<jats:sub>1-42<\/jats:sub> needs further investigation in CTE.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13195-022-00976-y","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T18:05:13Z","timestamp":1644429913000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["A comparison between tau and amyloid-\u03b2 cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease"],"prefix":"10.1186","volume":"14","author":[{"given":"Katherine W.","family":"Turk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Geada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor E.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Cherry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Nicks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoyuan","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Daley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yorghos","family":"Tripodis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand R.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E.","family":"Budson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigid","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil W.","family":"Kowall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Cantu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee E.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas I.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Alosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann C.","family":"McKee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6954-4477","authenticated-orcid":false,"given":"Thor D.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,9]]},"reference":[{"issue":"1","key":"976_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00401-015-1515-z","volume":"131","author":"AC McKee","year":"2016","unstructured":"McKee AC, Cairns NJ, Dickson DW, Folkerth RD, Keene CD, Litvan I, et al. The first NINDS\/NIBIB consensus meeting to define neuropathological criteria for the diagnosis of chronic traumatic encephalopathy. Acta Neuropathol. 2016;131(1):75\u201386.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"976_CR2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/BF00304630","volume":"85","author":"PR Hof","year":"1992","unstructured":"Hof PR, Bouras C, Buee L, Delacourte A, Perl DP, Morrison JH. Differential distribution of neurofibrillary tangles in the cerebral cortex of dementia pugilistica and Alzheimer\u2019s disease cases. Acta Neuropathol. 1992;85(1):23\u201330.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"976_CR3","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1007\/BF00308813","volume":"82","author":"T Tokuda","year":"1991","unstructured":"Tokuda T, Ikeda S, Yanagisawa N, Ihara Y, Glenner GG. Re-examination of ex-boxers' brains using immunohistochemistry with antibodies to amyloid beta-protein and tau protein. Acta Neuropathol. 1991;82(4):280\u20135.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"976_CR4","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/0197-4580(95)00021-6","volume":"16","author":"H Braak","year":"1995","unstructured":"Braak H, Braak E. Staging of Alzheimer\u2019s disease-related neurofibrillary changes. Neurobiol Aging. 1995;16(3):271\u20138 discussion 8-84.","journal-title":"Neurobiol Aging"},{"key":"976_CR5","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3389\/fneur.2019.00980","volume":"10","author":"A Katsumoto","year":"2019","unstructured":"Katsumoto A, Takeuchi H, Tanaka F. Tau pathology in chronic traumatic encephalopathy and Alzheimer\u2019s disease: similarities and differences. Front Neurol. 2019;10:980.","journal-title":"Front Neurol"},{"issue":"5","key":"976_CR6","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1007\/s004010000330","volume":"101","author":"ML Schmidt","year":"2001","unstructured":"Schmidt ML, Zhukareva V, Newell KL, Lee VM, Trojanowski JQ. Tau isoform profile and phosphorylation state in dementia pugilistica recapitulate Alzheimer\u2019s disease. Acta Neuropathol. 2001;101(5):518\u201324.","journal-title":"Acta Neuropathol"},{"key":"976_CR7","doi-asserted-by":"crossref","unstructured":"Ashton NJ, Leuzy A, Karikari TK, Mattsson-Carlgren N, Dodich A, Boccardi M, et al. The validation status of blood biomarkers of amyloid and phospho-tau assessed with the 5-phase development framework for AD biomarkers. Eur J Nucl Med Mol Imaging. 2021;48:2140-56.","DOI":"10.1007\/s00259-021-05253-y"},{"issue":"1","key":"976_CR8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13024-021-00430-x","volume":"16","author":"H Zetterberg","year":"2021","unstructured":"Zetterberg H, Blennow K. Moving fluid biomarkers for Alzheimer\u2019s disease from research tools to routine clinical diagnostics. Mol Neurodegener. 2021;16(1):10.","journal-title":"Mol Neurodegener"},{"issue":"2","key":"976_CR9","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3390\/brainsci11020215","volume":"11","author":"DA McGrowder","year":"2021","unstructured":"McGrowder DA, Miller F, Vaz K, Nwokocha C, Wilson-Clarke C, Anderson-Cross M, et al. Cerebrospinal fluid biomarkers of Alzheimer\u2019s disease: current evidence and future perspectives. Brain Sci. 2021;11(2):215.","journal-title":"Brain Sci"},{"issue":"1","key":"976_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13195-020-00601-w","volume":"12","author":"AJ Ehrenberg","year":"2020","unstructured":"Ehrenberg AJ, Khatun A, Coomans E, Betts MJ, Capraro F, Thijssen EH, et al. Relevance of biomarkers across different neurodegenerative diseases. Alzheimers Res Ther. 2020;12(1):56.","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"976_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00401-015-1435-y","volume":"130","author":"TD Stein","year":"2015","unstructured":"Stein TD, Montenigro PH, Alvarez VE, Xia W, Crary JF, Tripodis Y, et al. Beta-amyloid deposition in chronic traumatic encephalopathy. Acta Neuropathol. 2015;130(1):21\u201334.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"976_CR12","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s00401-020-02197-9","volume":"140","author":"ML Alosco","year":"2020","unstructured":"Alosco ML, Cherry JD, Huber BR, Tripodis Y, Baucom Z, Kowall NW, et al. Characterizing tau deposition in chronic traumatic encephalopathy (CTE): utility of the McKee CTE staging scheme. Acta Neuropathol. 2020;140(4):495\u2013512.","journal-title":"Acta Neuropathol"},{"issue":"12","key":"976_CR13","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1097\/nen.0b013e31815c5efb","volume":"66","author":"PT Nelson","year":"2007","unstructured":"Nelson PT, Jicha GA, Schmitt FA, Liu H, Davis DG, Mendiondo MS, et al. Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles \"do count\" when staging disease severity. J Neuropathol Exp Neurol. 2007;66(12):1136\u201346.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"976_CR14","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s13195-015-0148-8","volume":"7","author":"J Mez","year":"2015","unstructured":"Mez J, Solomon TM, Daneshvar DH, Murphy L, Kiernan PT, Montenigro PH, et al. Assessing clinicopathological correlation in chronic traumatic encephalopathy: rationale and methods for the UNITE study. Alzheimers Res Ther. 2015;7(1):62.","journal-title":"Alzheimers Res Ther"},{"issue":"9","key":"976_CR15","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1093\/jnen\/nly065","volume":"77","author":"JW Adams","year":"2018","unstructured":"Adams JW, Alvarez VE, Mez J, Huber BR, Tripodis Y, Xia W, et al. Lewy Body pathology and chronic traumatic encephalopathy associated with contact sports. J Neuropathol Exp Neurol. 2018;77(9):757\u201368.","journal-title":"J Neuropathol Exp Neurol"},{"issue":"Pt 1","key":"976_CR16","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1093\/brain\/aws307","volume":"136","author":"AC McKee","year":"2013","unstructured":"McKee AC, Stern RA, Nowinski CJ, Stein TD, Alvarez VE, Daneshvar DH, et al. The spectrum of disease in chronic traumatic encephalopathy. Brain. 2013;136(Pt 1):43\u201364.","journal-title":"Brain."},{"issue":"1","key":"976_CR17","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/ana.25123","volume":"83","author":"PA Boyle","year":"2018","unstructured":"Boyle PA, Yu L, Wilson RS, Leurgans SE, Schneider JA, Bennett DA. Person-specific contribution of neuropathologies to cognitive loss in old age. Ann Neurol. 2018;83(1):74\u201383.","journal-title":"Ann Neurol"},{"key":"976_CR18","doi-asserted-by":"crossref","unstructured":"Karanth S, Nelson PT, Katsumata Y, Kryscio RJ, Schmitt FA, Fardo DW, et al. Prevalence and clinical phenotype of quadruple misfolded proteins in older adults. JAMA Neurol. 2020;77(10):1299-307.","DOI":"10.1001\/jamaneurol.2020.1741"},{"issue":"3 Suppl","key":"976_CR19","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3233\/JAD-2006-9S347","volume":"9","author":"IG McKeith","year":"2006","unstructured":"McKeith IG. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. J Alzheimers Dis. 2006;9(3 Suppl):417\u201323.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"976_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-009-0612-2","volume":"119","author":"IR Mackenzie","year":"2010","unstructured":"Mackenzie IR, Neumann M, Bigio EH, Cairns NJ, Alafuzoff I, Kril J, et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol. 2010;119(1):1\u20134.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"976_CR21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00401-007-0237-2","volume":"114","author":"NJ Cairns","year":"2007","unstructured":"Cairns NJ, Bigio EH, Mackenzie IR, Neumann M, Lee VM, Hatanpaa KJ, et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol. 2007;114(1):5\u201322.","journal-title":"Acta Neuropathol"},{"issue":"1","key":"976_CR22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s40478-021-01189-4","volume":"9","author":"JD Cherry","year":"2021","unstructured":"Cherry JD, Esnault CD, Baucom ZH, Tripodis Y, Huber BR, Alvarez VE, et al. Tau isoforms are differentially expressed across the hippocampus in chronic traumatic encephalopathy and Alzheimer\u2019s disease. Acta Neuropathol Commun. 2021;9(1):86.","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"976_CR23","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1111\/bpa.12867","volume":"30","author":"JD Cherry","year":"2020","unstructured":"Cherry JD, Kim SH, Stein TD, Pothast MJ, Nicks R, Meng G, et al. Evolution of neuronal and glial tau isoforms in chronic traumatic encephalopathy. Brain Pathol. 2020;30(5):913\u201325.","journal-title":"Brain Pathol"},{"issue":"7752","key":"976_CR24","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/s41586-019-1026-5","volume":"568","author":"B Falcon","year":"2019","unstructured":"Falcon B, Zivanov J, Zhang W, Murzin AG, Garringer HJ, Vidal R, et al. Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules. Nature. 2019;568(7752):420\u20133.","journal-title":"Nature."},{"key":"976_CR25","doi-asserted-by":"publisher","unstructured":"Stathas S, Alvarez VE, Xia W, Nicks R, Meng G, Daley S, et al. Tau phosphorylation sites serine and serine are differently altered in chronic traumatic encephalopathy and Alzheimer\u2019s disease. Alzheimers Dement. 2021. https:\/\/doi.org\/10.1002\/alz.12502.","DOI":"10.1002\/alz.12502"},{"issue":"Pt 11","key":"976_CR26","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1093\/brain\/awl269","volume":"129","author":"K Buerger","year":"2006","unstructured":"Buerger K, Ewers M, Pirttila T, Zinkowski R, Alafuzoff I, Teipel SJ, et al. CSF phosphorylated tau protein correlates with neocortical neurofibrillary pathology in Alzheimer\u2019s disease. Brain. 2006;129(Pt 11):3035\u201341.","journal-title":"Brain."},{"issue":"3","key":"976_CR27","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1001\/archneurol.2008.596","volume":"66","author":"T Tapiola","year":"2009","unstructured":"Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, et al. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch Neurol. 2009;66(3):382\u20139.","journal-title":"Arch Neurol"},{"issue":"1","key":"976_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jalz.2007.08.006","volume":"4","author":"H Hampel","year":"2008","unstructured":"Hampel H, Burger K, Teipel SJ, Bokde AL, Zetterberg H, Blennow K. Core candidate neurochemical and imaging biomarkers of Alzheimer\u2019s disease. Alzheimers Dement. 2008;4(1):38\u201348.","journal-title":"Alzheimers Dement"},{"issue":"3","key":"976_CR29","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","volume":"5","author":"O Hansson","year":"2006","unstructured":"Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Association between CSF biomarkers and incipient Alzheimer\u2019s disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol. 2006;5(3):228\u201334.","journal-title":"Lancet Neurol"},{"issue":"4","key":"976_CR30","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1001\/jama.2009.1064","volume":"302","author":"N Mattsson","year":"2009","unstructured":"Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, et al. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. JAMA. 2009;302(4):385\u201393.","journal-title":"JAMA."},{"issue":"18","key":"976_CR31","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1056\/NEJMoa1900757","volume":"380","author":"RA Stern","year":"2019","unstructured":"Stern RA, Adler CH, Chen K, Navitsky M, Luo J, Dodick DW, et al. Tau positron-emission tomography in former national football league players. N Engl J Med. 2019;380(18):1716\u201325.","journal-title":"N Engl J Med"},{"issue":"3","key":"976_CR32","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00401-019-02031-x","volume":"138","author":"OJ Standring","year":"2019","unstructured":"Standring OJ, Friedberg J, Tripodis Y, Chua AS, Cherry JD, Alvarez VE, et al. Contact sport participation and chronic traumatic encephalopathy are associated with altered severity and distribution of cerebral amyloid angiopathy. Acta Neuropathol. 2019;138(3):401\u201313.","journal-title":"Acta Neuropathol"},{"issue":"3","key":"976_CR33","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1111\/bpa.12248","volume":"25","author":"AC McKee","year":"2015","unstructured":"McKee AC, Stein TD, Kiernan PT, Alvarez VE. The neuropathology of chronic traumatic encephalopathy. Brain Pathol. 2015;25(3):350\u201364.","journal-title":"Brain Pathol"},{"key":"976_CR34","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2147\/CLEP.S37929","volume":"6","author":"MM Mielke","year":"2014","unstructured":"Mielke MM, Vemuri P, Rocca WA. Clinical epidemiology of Alzheimer\u2019s disease: assessing sex and gender differences. Clin Epidemiol. 2014;6:37\u201348.","journal-title":"Clin Epidemiol"},{"issue":"1","key":"976_CR35","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1440-1819.1998.tb00981.x","volume":"52","author":"T Morihara","year":"1998","unstructured":"Morihara T, Kudo T, Ikura Y, Kashiwagi Y, Miyamae Y, Nakamura Y, et al. Increased tau protein level in postmortem cerebrospinal fluid. Psychiatry Clin Neurosci. 1998;52(1):107\u201310.","journal-title":"Psychiatry Clin Neurosci"},{"issue":"9","key":"976_CR36","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.jalz.2018.05.004","volume":"14","author":"ML Alosco","year":"2018","unstructured":"Alosco ML, Tripodis Y, Fritts NG, Heslegrave A, Baugh CM, Conneely S, et al. Cerebrospinal fluid tau, Abeta, and sTREM2 in Former National Football League Players: modeling the relationship between repetitive head impacts, microglial activation, and neurodegeneration. Alzheimers Dement. 2018;14(9):1159\u201370.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"976_CR37","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.3233\/JAD-151028","volume":"51","author":"RA Stern","year":"2016","unstructured":"Stern RA, Tripodis Y, Baugh CM, Fritts NG, Martin BM, Chaisson C, et al. Preliminary study of plasma exosomal tau as a potential biomarker for chronic traumatic encephalopathy. J Alzheimers Dis. 2016;51(4):1099\u2013109.","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"976_CR38","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1001\/jamaneurol.2014.367","volume":"71","author":"P Shahim","year":"2014","unstructured":"Shahim P, Tegner Y, Wilson DH, Randall J, Skillback T, Pazooki D, et al. Blood biomarkers for brain injury in concussed professional ice hockey players. JAMA Neurol. 2014;71(6):684\u201392.","journal-title":"JAMA Neurol"},{"key":"976_CR39","doi-asserted-by":"crossref","first-page":"233121651984009","DOI":"10.1177\/2331216519840094","volume":"23","author":"NJ Washnik","year":"2019","unstructured":"Washnik NJ, Anjum J, Lundgren K, Phillips S. A review of the role of auditory evoked potentials in mild traumatic brain injury assessment. Trends Hear. 2019;23:2331216519840094.","journal-title":"Trends Hear"},{"key":"976_CR40","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3389\/fnins.2019.01059","volume":"13","author":"S Muraoka","year":"2019","unstructured":"Muraoka S, Jedrychowski MP, Tatebe H, DeLeo AM, Ikezu S, Tokuda T, et al. Proteomic profiling of extracellular vesicles isolated from cerebrospinal fluid of former national football league players at risk for chronic traumatic encephalopathy. Front Neurosci. 2019;13:1059.","journal-title":"Front Neurosci"},{"issue":"6140","key":"976_CR41","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1126\/science.1240514","volume":"340","author":"M Nedergaard","year":"2013","unstructured":"Nedergaard M. Neuroscience. Garbage truck of the brain. Science. 2013;340(6140):1529\u201330.","journal-title":"Science"},{"issue":"1","key":"976_CR42","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1038\/s41467-020-15436-0","volume":"11","author":"S Janelidze","year":"2020","unstructured":"Janelidze S, Stomrud E, Smith R, Palmqvist S, Mattsson N, Airey DC, et al. Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer\u2019s disease. Nat Commun. 2020;11(1):1683.","journal-title":"Nat Commun"},{"issue":"7","key":"976_CR43","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1002\/alz.12283","volume":"17","author":"J Simren","year":"2021","unstructured":"Simren J, Leuzy A, Karikari TK, Hye A, Benedet AL, Lantero-Rodriguez J, et al. The diagnostic and prognostic capabilities of plasma biomarkers in Alzheimer\u2019s disease. Alzheimers Dement. 2021;17(7):1145\u201356.","journal-title":"Alzheimers Dement"},{"issue":"5","key":"976_CR44","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s00401-021-02275-6","volume":"141","author":"NJ Ashton","year":"2021","unstructured":"Ashton NJ, Pascoal TA, Karikari TK, Benedet AL, Lantero-Rodriguez J, Brinkmalm G, et al. Plasma p-tau231: a new biomarker for incipient Alzheimer\u2019s disease pathology. Acta Neuropathol. 2021;141(5):709\u201324.","journal-title":"Acta Neuropathol"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-00976-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-022-00976-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-022-00976-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T12:07:45Z","timestamp":1666526865000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-022-00976-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,9]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["976"],"URL":"https:\/\/doi.org\/10.1186\/s13195-022-00976-y","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,9]]},"assertion":[{"value":"13 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All study protocols were approved by the VA Bedford Healthcare System and Boston University Medical Center Institutional Review Boards. Written and informed consent was obtained from all patients and family members participating.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Andrew E. Budson has been a speaker for Eli Lilly, a consultant for General Electric, Eli Lilly, and Axovant. Lee E. Goldstein has received funding from the WWE and Ivivi Health Sciences. Robert A. Stern is a member of the Mackey-White Committee of the NFL Players Association. He is a paid consultant to BioGen (Cambridge, MA, USA) and Eli Lilly (Indianapolis, IN, USA). He receives royalties for published neuropsychological tests from Psychological Assessment Resources, Inc. (Lutz, FL, USA) and is a member of the Board of Directors of King-Devick Technologies (Chicago, IL, USA). Robert C. Cantu is a paid consultant to the NFL Head Neck and Spine Committee, NOCSAE, Concussion Legacy Foundation, receives royalties from book publications, and compensation from expert legal opinion. He is a member of the Mackey-White Committee of the NFL Players Association. Ann C. McKee is a member of the Mackey-White Committee of the NFL Players Association. The other authors have no competing interests or disclosures to report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}